SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-083453
Filing Date
2020-07-14
Accepted
2020-07-14 16:45:54
Documents
1
Period of Report
2020-07-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3890
  Complete submission text file 0001104659-20-083453.txt   5235
Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address
Harrison Seth Loring (Reporting) CIK: 0001404955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 201027489

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences